Edition:
United States

Aeterna Zentaris Inc (AEZS.O)

AEZS.O on Consolidated Issue listed on NASDAQ Capital Market

1.15USD
26 May 2017
Change (% chg)

$0.19 (+19.79%)
Prev Close
$0.96
Open
$0.97
Day's High
$1.21
Day's Low
$0.95
Volume
1,446,333
Avg. Vol
332,562
52-wk High
$5.59
52-wk Low
$0.78

Select another date:

Mon, May 1 2017

BRIEF-Aeterna Zentaris says ZoptEC Phase 3 clinical study of Zoptrex did not achieve primary endpoint

* Aeterna Zentaris announces that ZoptEC Phase 3 clinical study of Zoptrex did not achieve its primary endpoint

BRIEF-Aeterna Zentaris intends to file NDA with respect to Macrilen in Q3

* Aeterna Zentaris intends to file NDA with respect to Macrilen™ in third quarter of 2017 Source text for Eikon: Further company coverage:

BRIEF-Aeterna Zentaris files for common shares stock shelf offering of up to $50 mln

* Aeterna Zentaris Inc- files for common shares stock shelf offering of up to $50 million - sec filing Source text (http://bit.ly/2mMXM6t) Further company coverage:

BRIEF-Aeterna Zentaris qtrly loss per share $0.71

* Aeterna Zentaris reports fourth quarter and full-year 2016 financial and operating results

BRIEF-Aeterna Zentaris announces EMA pediatric committee agreement

* Aeterna Zentaris announces EMA pediatric committee agreement on the pediatric investigation plan for macrilen(TM)

Select another date:

More From Around the Web